Amicus Therapeutics, Inc. (FOLD)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
Amicus Therapeutics SG&A Expense (TTM) : 383.49M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 946.91M |
| Insmed, Inc. | 701.17M |
| Ligand Pharmaceuticals, Inc. | 92.45M |
| PTC Therapeutics, Inc. | 347.14M |
| Establishment Labs Holdings, Inc. | 125.37M |